Living-donor kidney transplantation at Mayo Clinic--Rochester.

Mark D Stegall, Timothy S. Larson, Mikel Prieto, James Gloor, Stephen C Textor, Scott Nyberg, Sylvester Sterioff, Michael Ishitani, Matthew Griffin, Thomas Schwab, Sandra Talor, Fernando G Cosio, Yogish C Kudva, Deborah Dicke-Henslin, Michelle Kreps, Lynette Fix, Cherise Bauer, Mary Murphy, Kay Kosberg, Deborah TararaJorge Velosa

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

With the established benefits of living-donor kidney transplantation, our primary emphasis at Mayo Clinic, Rochester has been to develop protocols that allow living donation to occur even in the presence of relatively unusual or generally contraindicated situations. This approach has significantly increased the number of patients receiving kidney transplants in the past few years. Our protocols for extended criteria donors and recipients along with the exclusive use of laparoscopic donor nephrectomy have been major contributors to the increase in volume. ABO-incompatible and positive-crossmatch living-donor kidney transplant protocols also have increased the availability of transplants for our patients. Protocol biopsies have aided in the diagnosis of subclinical rejection, polyoma virus and chronic allograft nephropathy. Innovative immunosuppressive protocols such as calcineurin inhibitor-free immunosuppression have decreased rejection and improved both short and long-term renal allograft survival.

Original languageEnglish (US)
Pages (from-to)155-161
Number of pages7
JournalClinical transplants
StatePublished - 2002

Fingerprint

Living Donors
Kidney Transplantation
Transplants
Kidney
Allografts
Tissue Donors
Polyomavirus
Immunosuppressive Agents
Nephrectomy
Immunosuppression
Biopsy

Cite this

Living-donor kidney transplantation at Mayo Clinic--Rochester. / Stegall, Mark D; Larson, Timothy S.; Prieto, Mikel; Gloor, James; Textor, Stephen C; Nyberg, Scott; Sterioff, Sylvester; Ishitani, Michael; Griffin, Matthew; Schwab, Thomas; Talor, Sandra; Cosio, Fernando G; Kudva, Yogish C; Dicke-Henslin, Deborah; Kreps, Michelle; Fix, Lynette; Bauer, Cherise; Murphy, Mary; Kosberg, Kay; Tarara, Deborah; Velosa, Jorge.

In: Clinical transplants, 2002, p. 155-161.

Research output: Contribution to journalArticle

Stegall, MD, Larson, TS, Prieto, M, Gloor, J, Textor, SC, Nyberg, S, Sterioff, S, Ishitani, M, Griffin, M, Schwab, T, Talor, S, Cosio, FG, Kudva, YC, Dicke-Henslin, D, Kreps, M, Fix, L, Bauer, C, Murphy, M, Kosberg, K, Tarara, D & Velosa, J 2002, 'Living-donor kidney transplantation at Mayo Clinic--Rochester.', Clinical transplants, pp. 155-161.
Stegall, Mark D ; Larson, Timothy S. ; Prieto, Mikel ; Gloor, James ; Textor, Stephen C ; Nyberg, Scott ; Sterioff, Sylvester ; Ishitani, Michael ; Griffin, Matthew ; Schwab, Thomas ; Talor, Sandra ; Cosio, Fernando G ; Kudva, Yogish C ; Dicke-Henslin, Deborah ; Kreps, Michelle ; Fix, Lynette ; Bauer, Cherise ; Murphy, Mary ; Kosberg, Kay ; Tarara, Deborah ; Velosa, Jorge. / Living-donor kidney transplantation at Mayo Clinic--Rochester. In: Clinical transplants. 2002 ; pp. 155-161.
@article{a93e6cc3b8f843719f21e81c5db6022f,
title = "Living-donor kidney transplantation at Mayo Clinic--Rochester.",
abstract = "With the established benefits of living-donor kidney transplantation, our primary emphasis at Mayo Clinic, Rochester has been to develop protocols that allow living donation to occur even in the presence of relatively unusual or generally contraindicated situations. This approach has significantly increased the number of patients receiving kidney transplants in the past few years. Our protocols for extended criteria donors and recipients along with the exclusive use of laparoscopic donor nephrectomy have been major contributors to the increase in volume. ABO-incompatible and positive-crossmatch living-donor kidney transplant protocols also have increased the availability of transplants for our patients. Protocol biopsies have aided in the diagnosis of subclinical rejection, polyoma virus and chronic allograft nephropathy. Innovative immunosuppressive protocols such as calcineurin inhibitor-free immunosuppression have decreased rejection and improved both short and long-term renal allograft survival.",
author = "Stegall, {Mark D} and Larson, {Timothy S.} and Mikel Prieto and James Gloor and Textor, {Stephen C} and Scott Nyberg and Sylvester Sterioff and Michael Ishitani and Matthew Griffin and Thomas Schwab and Sandra Talor and Cosio, {Fernando G} and Kudva, {Yogish C} and Deborah Dicke-Henslin and Michelle Kreps and Lynette Fix and Cherise Bauer and Mary Murphy and Kay Kosberg and Deborah Tarara and Jorge Velosa",
year = "2002",
language = "English (US)",
pages = "155--161",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Living-donor kidney transplantation at Mayo Clinic--Rochester.

AU - Stegall, Mark D

AU - Larson, Timothy S.

AU - Prieto, Mikel

AU - Gloor, James

AU - Textor, Stephen C

AU - Nyberg, Scott

AU - Sterioff, Sylvester

AU - Ishitani, Michael

AU - Griffin, Matthew

AU - Schwab, Thomas

AU - Talor, Sandra

AU - Cosio, Fernando G

AU - Kudva, Yogish C

AU - Dicke-Henslin, Deborah

AU - Kreps, Michelle

AU - Fix, Lynette

AU - Bauer, Cherise

AU - Murphy, Mary

AU - Kosberg, Kay

AU - Tarara, Deborah

AU - Velosa, Jorge

PY - 2002

Y1 - 2002

N2 - With the established benefits of living-donor kidney transplantation, our primary emphasis at Mayo Clinic, Rochester has been to develop protocols that allow living donation to occur even in the presence of relatively unusual or generally contraindicated situations. This approach has significantly increased the number of patients receiving kidney transplants in the past few years. Our protocols for extended criteria donors and recipients along with the exclusive use of laparoscopic donor nephrectomy have been major contributors to the increase in volume. ABO-incompatible and positive-crossmatch living-donor kidney transplant protocols also have increased the availability of transplants for our patients. Protocol biopsies have aided in the diagnosis of subclinical rejection, polyoma virus and chronic allograft nephropathy. Innovative immunosuppressive protocols such as calcineurin inhibitor-free immunosuppression have decreased rejection and improved both short and long-term renal allograft survival.

AB - With the established benefits of living-donor kidney transplantation, our primary emphasis at Mayo Clinic, Rochester has been to develop protocols that allow living donation to occur even in the presence of relatively unusual or generally contraindicated situations. This approach has significantly increased the number of patients receiving kidney transplants in the past few years. Our protocols for extended criteria donors and recipients along with the exclusive use of laparoscopic donor nephrectomy have been major contributors to the increase in volume. ABO-incompatible and positive-crossmatch living-donor kidney transplant protocols also have increased the availability of transplants for our patients. Protocol biopsies have aided in the diagnosis of subclinical rejection, polyoma virus and chronic allograft nephropathy. Innovative immunosuppressive protocols such as calcineurin inhibitor-free immunosuppression have decreased rejection and improved both short and long-term renal allograft survival.

UR - http://www.scopus.com/inward/record.url?scp=0142026095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142026095&partnerID=8YFLogxK

M3 - Article

C2 - 12971445

AN - SCOPUS:0142026095

SP - 155

EP - 161

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -